🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

microRNA-371 during follow-up protocol of men with localised #testicular #germcell tumors. #BeyondTheAbstract with Christian D. Fankhauser on recent work in British Journal of Cancer. #ReadNow on UroToday > bit.ly/3GsFzVp silke gillessen @rothermundtc Marian S. Wettstein Nico Grossmann

TUMOR STENTS Reinforced middle shaft. Theoretically max = 6 months. We found >50% premature stent failures. Comparable to Tatsu Yama Resonance (55% at 6 months). liebertpub.com/doi/10.1089/en… liebertpub.com/doi/10.1089/en… Daniel Eberli Cédric Poyet Nico Grossmann Marian S. Wettstein Uwe Bieri PEARLS

how implementation science may change practice: -in our randomized trial Luzerner Kantonsspital we hypothesize that nurse led smoking cessation before major surgery improves surgical outcomes NCT05192837 Krebsforschung Schweiz Milo Puhan Ulrike Held

🦾largest minimally invasive RPLND cohort rdcu.be/cIQxf Luca Afferi SPStroup Kathleen Olson, MD DrBagrodia Walter Cazzaniga Stephane de Vergie Ragheed Saoud Scott Eggener Lee Hugar, MD MSCR Wade J Sexton Joseph Cheaib Phillip Pierorazio Rob Hamilton Agostino Mattei

بتوفيق الله تم نشر بحثي اليوم بتاريخ 30.03.2022 Do we need #BT in addition to #EBRT as part of #multimodal RT for high-risk PCa to be comparable with #RP? Pawel Rajwa Ekaterina Laukhtina Mohammad Abufaraj Nico Grossmann Reza Sari Motlagh Victor Schuettfort Benjamin Pradere tandfonline.com/doi/full/10.10…

Quality Care Metrics r necessary for 🦀 management. Establishing quality indicators for UTUC may define prognosis and ↗️ patient care Our ⭐️collaborative group has proposed a Pentafecta 🚫Margin 🚫early Reccurence 🚫major 🚫🩸 Complication Bladder cuff mdpi.com/2072-6694/14/7…

We used commercially available cell lines for the identification of novel drugs for the treatment of bladder cancer. We confirmed the effects of one of these drugs, clofarabine, in patient-derived cell lines and two different mouse models. sciencedirect.com/science/articl…

Master peace driven by the fantastic Hadi Mostafaei that depicts the role of #placebo & #nocebo in functional urology! A must read for all our friends Benoît Peyronnet Jean-Nicolas Cornu @GregoireRob Kari Tikkinen Vincent Ⓜ️israi Véronique Phé Christian Gratzke Dean Elterman nature.com/articles/s4158…

🇨🇭New research fellowship starting 2023 in Lucerne, most beautiful city in Switzerland🇨🇭 ⁉️ keen on systematic lit reviews, meta-analyses, advanced data analyses of retrospective multicenter data or prospective trials in urooncology

how a simple institutional work-flow saved a young man from an unnecessary orchiectomy and ionizing radiation of a CT scan DrBagrodia Sia Daneshmand, M.D. Amir Salmasi Dr. Hooman Djaladat Prof Asif Muneer Maarten Albersen Rich Matulewicz silke gillessen Christoph_Oing Arie Parnham

The future of minimally invasive surgery is bright! Smaller and smaller accesses, alternative techniques, markers, image guided surgery... There was so much to learn from Simone Crivellaro this evening! Thank you! Innovation is the key to move forward Luzerner Kantonsspital

Thrilled that active surveillance for #BladderCancer has made it into #EAU23 Guidelines European Association of Urology (EAU) Paolo Gontero Morgan Roupret Watch out for data from Wei Shen Tan IBCG Roberto Contieri Valentina Grajales MD, MS MD Anderson Cancer Center on this topic YUO Amer. Urol. Assn. Bladder Cancer Advocacy Network Society of Urologic Oncology

It’s time for a paradigm change and offer radical surgery only in more advanced disease? thelancet.com/journals/lanon…

Honored to have Prof. Giorgio Gandaglia from Ospedale San Raffaele visiting us last week Luzerner Kantonsspital. He gave us a great overview of nodal staging and evidence for nodal dissection for prostate cancer patients. Still many open questions, but some studies ongoing 🎯

👀 TAR-210 the Phase 1 study Intravesical Erdafitinib in HR and IR NMIBC In patient w/ FGFR alteration 🟢IR-NMIBC 87% CR in a CHEMOABLATION setting!! 🔵HR-NMIBC 82% CR ➡️intravesical treatment has a great futur!! No more TURBT soon 🥺?

🚨 In patients undergoing high-risk surgeries, like cystectomies, managing allergies is crucial! see 🧵 our newest paper cambridge.org/core/journals/…

Vienna fellowship friendship dinner 🥳#EAU24 Shahrokh F. Shariat Urologic Oncology Research MedUni Vienna Benjamin Pradere Keiichiro Mori Pawel Rajwa Tamas Fazekas MD Fahad Quhal فهد قحل MPallauf Nico Grossmann Takafumi Yanagisawa Tatsushi Kawada Marcin Ch

Honored to be part of the team that helped to perform the first SP Intuitive case #Kantonsspital Luzern, Switzerland with Prof A. Mattei. EP RALP and RP pyeloplasty. He was impressed by regionalization ability of the SP. Glad to represent HackensackUMC Department of Urology Amer. Urol. Assn.

Excited to see the energy and dedication of the new YAU group at the Lisbon ~#EMUC24 ! Looking forward to their contributions to advancing research in urology and fostering collaboration across borders. #YAU #YoungUrologists #Research #Collaboration”

EAU Young Academics meeting in Lisbon🇵🇹! Infection working group was there, along with the French 🇫🇷 delegation! What a pleasure to work together in such a warm and welcoming atmosphere! 🙏 to our past chairman Juan Gómez Rivas and our new chairman Giorgio I. Russo 🩺 for this 🤩 handover!